Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06060834 · ClinicalTrials.gov registry record · NA
Impact of a Topical Cosmetic Product on Women's Hair
A NA study of Hair Thinning and Hair Loss, sponsored by University of Memphis.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT06060834: Completed NA study of Hair Thinning and Hair Loss, sponsored by University of Memphis.
NCT06060834 is a NA study of Hair Thinning and Hair Loss that has completed, run by University of Memphis. The registered enrollment target is 14 participants, below the 64-participant average among 10 other Hair Thinning trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06060834, a NA study of Hair Thinning and Hair Loss, has completed, sponsored by University of Memphis.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed pilot study will investigate the impact of a daily topical nutritional product applied to women's hair, specific to perceived hair quality and overall well-being. Hair loss will be measured with a scanning application ("MyHairCounts") , as well as with the 60-second hair comb test. This will be an open-label study with a sample of 15 women and will be used to generate pilot data for future, larger-scale placebo-controlled studies.
Primary Outcome
Hair density as determined by "MyHairCounts" application
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Topical Botanical Agent
Study Locations (1)
Tennessee
- Center for Nutraceutical and Dietary Supplement Research - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2023-08-03 |
| Est. Completion | 2024-01-25 |
| Phase | NA |
What the finished NCT06060834 record still lists
NCT06060834 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 64-participant average among 10 other Hair Thinning trials with a reported enrollment target (78% lower).
The record links to 2 conditions, with Hair Thinning appearing as the primary indexed condition, and to 1 intervention - of which Topical Botanical Agent is the first listed.
NCT06060834 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT06060834 about?
NCT06060834 is a clinical study titled "Impact of a Topical Cosmetic Product on Women's Hair". The proposed pilot study will investigate the impact of a daily topical nutritional product applied to women's hair, specific to perceived hair quality and overall well-being. Hair loss will be measured with a scanning application ("MyHairCounts") , as well as with the 60-second hair comb test. This...
What is the current status of trial NCT06060834?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2023-08-03. Estimated completion is 2024-01-25.
What conditions does trial NCT06060834 study?
This clinical trial studies the following conditions: Hair Thinning, Hair Loss.
What interventions are being tested in trial NCT06060834?
The interventions under investigation include: Topical Botanical Agent (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06060834?
This trial is sponsored by University of Memphis, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06060834 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hair Thinning
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06060834's enrollment target sits among peer trials
14 11th of 10 the lowest of 10 other Hair Thinning trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hair Thinning trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Combined Use of Supplement and Serum in Promoting Hair Growth in Women With Self-perceived Thinning Hair
RECRUITING · NA
-
A Clinical Trial to Examine the Efficacy of a Dietary Supplement to Improve the Health and Appearance of Hair.
ACTIVE NOT RECRUITING · NA
-
A Clinical Trial to Examine the Efficacy of a Supplement to Support Healthy Hair and Skin
ACTIVE NOT RECRUITING · NA
-
Efficacy and Safety of TargetCool + Benev Exosomes in Patients With Hair Thinning
ACTIVE NOT RECRUITING · NA
-
The Effects of an Oral Hair Supplement on Hair Density, Growth, and Microbiome
ACTIVE NOT RECRUITING · NA
-
Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Women With Thinning Hair
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy